Schedule 13G ownership disclosure

Tarsus Pharmaceuticals Inc

Security class unavailable · CUSIP: 87650L103

Event date: 2020-10-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-20-001063
Form type
SC 13G
Filer
Cormorant Asset Management, LP
CIK
CIK 1583977
Filed
Oct 30, 2020
Reporting period
Oct 20, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub